SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Sold by Mathes Company Inc.

Mathes Company Inc. trimmed its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 3.4% in the 3rd quarter, HoldingsChannel reports. The institutional investor owned 9,115 shares of the exchange traded fund’s stock after selling 325 shares during the period. Mathes Company Inc.’s holdings in SPDR S&P Biotech ETF were worth $901,000 at the end of the most recent reporting period.

Several other large investors have also made changes to their positions in XBI. Affinity Asset Advisors LLC increased its position in shares of SPDR S&P Biotech ETF by 105.4% during the second quarter. Affinity Asset Advisors LLC now owns 37,550 shares of the exchange traded fund’s stock worth $3,481,000 after purchasing an additional 737,550 shares in the last quarter. Healthcare of Ontario Pension Plan Trust Fund grew its holdings in SPDR S&P Biotech ETF by 30.3% in the 1st quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 3,136,000 shares of the exchange traded fund’s stock valued at $297,575,000 after buying an additional 730,000 shares in the last quarter. Mirae Asset Securities USA Inc. purchased a new stake in SPDR S&P Biotech ETF in the 2nd quarter valued at $55,626,000. Jane Street Group LLC grew its holdings in SPDR S&P Biotech ETF by 68.7% in the 1st quarter. Jane Street Group LLC now owns 961,082 shares of the exchange traded fund’s stock valued at $91,197,000 after buying an additional 391,333 shares in the last quarter. Finally, Baymount Management LP purchased a new stake in SPDR S&P Biotech ETF in the 1st quarter valued at $34,160,000.

SPDR S&P Biotech ETF Stock Up 2.3 %

Shares of NYSEARCA:XBI opened at $99.27 on Friday. The business has a fifty day moving average of $98.88 and a two-hundred day moving average of $94.90. The stock has a market cap of $7.57 billion, a P/E ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a 52-week low of $64.99 and a 52-week high of $103.52.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.